Congenital thrombotic thrombocytopenic purpura (cTTP) with two novel mutations

Timothy D. Prestidge, Erica Rurali, Louis Wadsworth, John K. Wu, Jane C. Moore, Elena Bresin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare disorder of childhood that has clinical and laboratory similarities to other, more common conditions. Prompt recognition is required as delays in therapy are associated with significant morbidity and failure to treat may lead to death. While the principles of treatment have not changed, enormous progress in the genetic and molecular understanding has taken place. Emerging treatment options may offer some hope of improved quality of life in future. We describe a Chinese patient with cTTP which resulted from two previously undescribed mutations in the ADAMTS13 gene.

Original languageEnglish
Pages (from-to)1296-1298
Number of pages3
JournalPediatric Blood and Cancer
Volume59
Issue number7
DOIs
Publication statusPublished - Dec 15 2012

Fingerprint

Thrombotic Thrombocytopenic Purpura
Mutation
Molecular Biology
Therapeutics
Quality of Life
Morbidity
Genes

Keywords

  • ADAMTS13 protein
  • Congential thrombotic thrombocytopenic purpura
  • Hematology
  • Pediatrics
  • Thrombotic microangiopathy

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Congenital thrombotic thrombocytopenic purpura (cTTP) with two novel mutations. / Prestidge, Timothy D.; Rurali, Erica; Wadsworth, Louis; Wu, John K.; Moore, Jane C.; Bresin, Elena.

In: Pediatric Blood and Cancer, Vol. 59, No. 7, 15.12.2012, p. 1296-1298.

Research output: Contribution to journalArticle

Prestidge, Timothy D. ; Rurali, Erica ; Wadsworth, Louis ; Wu, John K. ; Moore, Jane C. ; Bresin, Elena. / Congenital thrombotic thrombocytopenic purpura (cTTP) with two novel mutations. In: Pediatric Blood and Cancer. 2012 ; Vol. 59, No. 7. pp. 1296-1298.
@article{76d7ac7bf77145f28c866729200fe81b,
title = "Congenital thrombotic thrombocytopenic purpura (cTTP) with two novel mutations",
abstract = "Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare disorder of childhood that has clinical and laboratory similarities to other, more common conditions. Prompt recognition is required as delays in therapy are associated with significant morbidity and failure to treat may lead to death. While the principles of treatment have not changed, enormous progress in the genetic and molecular understanding has taken place. Emerging treatment options may offer some hope of improved quality of life in future. We describe a Chinese patient with cTTP which resulted from two previously undescribed mutations in the ADAMTS13 gene.",
keywords = "ADAMTS13 protein, Congential thrombotic thrombocytopenic purpura, Hematology, Pediatrics, Thrombotic microangiopathy",
author = "Prestidge, {Timothy D.} and Erica Rurali and Louis Wadsworth and Wu, {John K.} and Moore, {Jane C.} and Elena Bresin",
year = "2012",
month = "12",
day = "15",
doi = "10.1002/pbc.24159",
language = "English",
volume = "59",
pages = "1296--1298",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Congenital thrombotic thrombocytopenic purpura (cTTP) with two novel mutations

AU - Prestidge, Timothy D.

AU - Rurali, Erica

AU - Wadsworth, Louis

AU - Wu, John K.

AU - Moore, Jane C.

AU - Bresin, Elena

PY - 2012/12/15

Y1 - 2012/12/15

N2 - Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare disorder of childhood that has clinical and laboratory similarities to other, more common conditions. Prompt recognition is required as delays in therapy are associated with significant morbidity and failure to treat may lead to death. While the principles of treatment have not changed, enormous progress in the genetic and molecular understanding has taken place. Emerging treatment options may offer some hope of improved quality of life in future. We describe a Chinese patient with cTTP which resulted from two previously undescribed mutations in the ADAMTS13 gene.

AB - Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare disorder of childhood that has clinical and laboratory similarities to other, more common conditions. Prompt recognition is required as delays in therapy are associated with significant morbidity and failure to treat may lead to death. While the principles of treatment have not changed, enormous progress in the genetic and molecular understanding has taken place. Emerging treatment options may offer some hope of improved quality of life in future. We describe a Chinese patient with cTTP which resulted from two previously undescribed mutations in the ADAMTS13 gene.

KW - ADAMTS13 protein

KW - Congential thrombotic thrombocytopenic purpura

KW - Hematology

KW - Pediatrics

KW - Thrombotic microangiopathy

UR - http://www.scopus.com/inward/record.url?scp=84867370001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867370001&partnerID=8YFLogxK

U2 - 10.1002/pbc.24159

DO - 10.1002/pbc.24159

M3 - Article

C2 - 22488907

AN - SCOPUS:84867370001

VL - 59

SP - 1296

EP - 1298

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 7

ER -